Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib

Blood

Volumn 93, Issue 6, 1999, Pages 1959-1968

  Obert, Bernadette ^a   Houllier, Anne ^a   Meyer, Dominique ^a   Girma, Jean Pierre ^a,b  

^a INSERM   (France)

^b Dept Environ Med Natl Inst Publ HIth   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BITISCETIN; BOTROCETIN; EPITOPE; GLYCOPROTEIN IB; RISTOCETIN; SNAKE VENOM; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; REGULATORY MECHANISM; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0033559304     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.6.1959.406k01_1959_1968     Document Type: Article

References (55)

1. Weiss HJ, Turitto VT, Baumgartner HR: Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med 92:750, 1978
2. Siedlecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE: Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 88:2939, 1996
3. Miyata S, Goto S, Federici AB, Ware J, Ruggeri ZM: Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ib alpha. J Biol Chem 271:9046, 1996
4. Kroll MH, Hellums JD, Mcintire LV, Schafer AI, Moake JL: Platelets and shear stress. Blood 88:1525, 1996
5. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM: Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 270:23352, 1995
6. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234, 1991
7. Hamako J, Matsui T, Suzuki M, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K: Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom. Biochem Biophys Res Commun 226:273, 1996
8. Colombatti A, Bonaldo P: The superfamily of proteins with von Willebrand factor type-A-like domains. One theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77:2305, 1991
9. Colombatti A, Bonaldo P, Doliana R: Type-A modules. Interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins. Matrix 13:297, 1993
10. Joba W, Hoffmann W: Similarities of integumentary mucin B.1 from Xenopus laevis and prepro-von Willebrand factor at their aminoterminal regions. J Biol Chem 272:1805, 1997
11. Kotani E, Yamakawa M, Iwamoto S, Tashiro M, Mori H, Sumida M, Matsubara F, Taniai K, Kadonookuda K, Kato Y, Mori H: Cloning and expression of the gene of hemocytin, an insect humoral lectin that is homologous with the mammalian von Willebrand factor. Biochim Biophys Acta 1260:245, 1995
12. Legan PK, Rau A, Keen JN, Richardson GP: The mouse tectorins. Modular matrix proteins of the inner ear homologous to components of the sperm-egg adhesion system. J Biol Chem 272:8791, 1997
13. Colombatti A, Doliana R: The superfamily with Von Willebrand Factor VA domains, in Molecular Biology Intelligence Unit. Georgetown, TX, RG Landes, 1996
14. Toribara NW, Ho SB, Gum JR, Lau P, Kim YS: The carboxyl-terminal sequence of the human secretory mucin, MUC6. Analysis of the primary amino acid sequence. J Biol Chem 272:16398, 1997
15. Matsushita T, Sadler JE: Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor. J Biol Chem 270:13406, 1995
16. Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 71:520, 1994
17. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews R: Identification of aspartic acid-514 through glutamic acid-542 as a glycoprotein-Ib-IX complex receptor recognition sequence in von Willebrand factor - Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 31:11144, 1992
18. Sugimoto M, Mohri H, Mcclintock RA, Ruggeri ZM: Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein-Ib. J Biol Chem 266:18172, 1991
19. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D: Ristocetin and botrocetin involve two distinct domains of von Willebrand Factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost 64:326, 1990
20. Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri ZM, Zimmerman TS: Structure of the von Willebrand Factor domain interacting with glycoprotein Ib. J Biol Chem 263:17901, 1988
21. Sugimoto M, Dent J, Mcclintock R, Ware J, Ruggeri ZM: Analysis of structure function relationships in the platelet membrane glycoprotein Ib-binding domain of von Willebrand factor by expression of deletion mutants. J Biol Chem 268:12185, 1993
22. Christophe O, Obert B, Meyer D, Girma JP: The binding domain of von Willebrand Factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood 78:2310, 1991
23. Sobel M, Soler DF, Kermode JC, Harris RB: Localization and characterization of a heparin binding domain peptide of human von Willebrand Factor. J Biol Chem 267:8857, 1992
24. Sobel M, Mcneill PM, Carlson PL, Kermode JC, Adelman B, Conroy R, Marques D: Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest 87:1787, 1991
25. Andrews RK, Booth WJ, Bendall LJ, Berndt MC: The amino acid sequence glutamine-628 to valine-646 within the A1 repeat domain mediates binding of von Willebrand factor to bovine brain sulfatides and equine tendon collagen. Platelets 6:245, 1995
26. Kroner PA, Frey AB: Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis. Biochemistry 35:13460, 1996
27. Kalafatis M, Takahashi Y, Girma JP, Meyer D: Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1365. Blood 70:1577, 1987
28. Pareti FI, Niiya K, McPherson JM, Ruggeri ZM: Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 262:13835, 1987
29. Lankhof H, Vanhoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, Degroot PG, Sixma JJ: A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost 75:950, 1996
30. Cruz MA, Yuan HB, Lee JR, Wise RJ, Handin RI: Interaction of the von Willebrand factor (VWF) with collagen - Localization of the primary collagen-binding site by analysis of recombinant vWF A domain polypeptides. J Biol Chem 270:10822, 1995
31. Huizinga EG, vanderPlas RM, Kroon J, Sixma JJ, Gros P: Crystal structure of the A3 domain of human von Willebrand factor: Implications for collagen binding. Structure 5:1147, 1997
32. Matsui T, Kunishima S, Hamako J, Katayama M, Kamiya T, Naoe T, Ozeki Y, Fujimura Y, Titani K: Interaction of von Willebrand factor with the extracellular matrix and glycocalicin under static conditions. J Biochem 121:376, 1997
33. Allain JP, Cooper HA, Wagner RH, Brinkhous KM: Platelets fixed with paraformaldehyde: A new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med 85:318, 1975
34. Laemmli UK: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680, 1970
35. Towbin H, Stachelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
36. Christophe O, Ribba AS, Baruch D, Obert B, Rouault C, Niinomi K, Pietu G, Meyer D, Girma JP: Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor. Blood 83:3553, 1994
37. Fraker PJ, Speck JC: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 80:849, 1978
38. Ribba AS, Voorberg J, Meyer D, Pannekoek H, Pietu G: Characterization of recombinant von Willebrand factor corresponding to mutations in type-IIA and type-IIB von Willebrand disease. J Biol Chem 267:23209, 1992
39. Chang DC: Design of protocols for electroporation and electrofusion: selection of electrical parameters, in Chang DC, Cassy BM, Saunders JA, Sowers AE: Guide to Electroporation and Electrofusion. San Diego, CA, Academic, 1992, p 429
40. Girma JP, Chopek MW, Titani K, Davie EW: Limited proteolysis of human von Willebrand factor by staphylococcus aureus V-8 protease: Isolation and partial characterization of a platelet-binding domain. Biochemistry 25:3156, 1986
41. Girma JP, Kalafatis M, Pietu G, Lavergne JM, Chopek MW, Edgington TS, Meyer D: Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Blood 67:1356, 1986
42. Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC: Cross linking of a monomeric 39/34 kDa dispase fragment of von Willebrand factor (Leu 480/Val 481-Gly 718) to the N-terminal region of the a-chain of membrane glycoprotein Ib on the intact platelets with bis (sulfosuccinimidyl) suberate. Biochemistry 28:8326, 1989
43. Meyer D, Zimmerman TS, Obert B, Edgington TS: Hybridoma antibodies to human von Willebrand factor. I. Characterization of seven clones. Br J Haematol 57:597, 1984
44. Christophe O, Rouault C, Obert B, Pietu G, Meyer D, Girma JP: A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease. Br J Haematol 90:195, 1995
45. Depraetere H, Ajzenberg N, Girma JP, Lacombe C, Meyer D, Deckmyn H, Baruch D: Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor. Blood 91:3792, 1998
46. Layet S, Girma JP, Obert B, Peynaud-Debayle E, Bihoreau N, Meyer D: Evidence that a secondary binding and protecting site for Factor VIII on von Willebrand factor is highly unlikely. Biochem J 282:129, 1992
47. Coller BC, Peerschke EI, Scudder LE, Sullivan CA: Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand Factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand Factor. Blood 61:99, 1983
48. Merrifield RB, Steward JM, Jernberg N: Instrument for automated synthesis of peptides. Anal Chem 38:1905, 1966
49. Pietu G, Ribba AS, Cherel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D: Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries. Thromb Haemost 71:788, 1994
50. Scott JP, Montgomery RR, Retzinger GS: Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J Biol Chem 266:8149, 1991
51. Ginsburg D, Sadler JE: von Willebrand disease. A database of point mutations, insertions, and deletions. Thromb Haemost 69:177, 1993
52. Rabinowitz I, Randi AM, Shindler KS, Tuley EA, Rustagi PK, Sadler JE: Type-IIB mutation His-505 → Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein-Ib. J Biol Chem 268:20497, 1993
53. Hilbert L, Gaucher C, De Romeuf C, Horellou MH, Vink T, Mazurier C: Leu 697 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood 83:1542, 1994
54. Hilbert L, Gaucher C, Mazurier C : Effects of different aminoacid substitutions in the leucine 649-proline 708 segment of recombinant von Willebrand factor. Br J Haematol 91:983, 1995
55. Berndt MC, Ward CM, Deluca M, Facey DA, Castaldi PA, Harris SJ, Andrews RK: The molecular mechanism of platelet adhesion. Aust N Z J Med 25:822, 1995